Prognostic impact of the Gustave Roussy Immune score in metastatic renal cell carcinoma treated with first-line immunotherapy-based combinations: results from the Turkish Oncology Group Kidney Cancer Consortium (TKCC)

Aysun Fatma Akkuş, Hatice Bölek, Esma Kaplan Tüzün, Elif Serteşen Camöz, Safa Can Efil, Murad Guliyev, Selver Işık, Caner Kapar, Serhat Sekmek, Halil Göksel Güzel, Sercan Ön, Sema Sezin Göksu, Özlem Nuray Sever, Çagatay Arslan, Nuri Karadurmuş, Musfafa Özgüroğlu, Mehmet Ali Nahit Sendur, Deniz Tural, Muhammet Bekir Hacıoğlu, Emre Yekedüz, Yüksel Ürün

Open source

DOI: 10.1186/s12885-026-16664-1
Published: 2026-08-06
Container: BMC Cancer
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12885-026-16664-1,
  title = {Prognostic impact of the Gustave Roussy Immune score in metastatic renal cell carcinoma treated with first-line immunotherapy-based combinations: results from the Turkish Oncology Group Kidney Cancer Consortium (TKCC)},
  author = {Aysun Fatma Akkuş and Hatice Bölek and Esma Kaplan Tüzün and Elif Serteşen Camöz and Safa Can Efil and Murad Guliyev and Selver Işık and Caner Kapar and Serhat Sekmek and Halil Göksel Güzel and Sercan Ön and Sema Sezin Göksu and Özlem Nuray Sever and Çagatay Arslan and Nuri Karadurmuş and Musfafa Özgüroğlu and Mehmet Ali Nahit Sendur and Deniz Tural and Muhammet Bekir Hacıoğlu and Emre Yekedüz and Yüksel Ürün},
  year = {2026},
  journal = {BMC Cancer},
  doi = {10.1186/s12885-026-16664-1},
  url = {https://doi.org/10.1186/s12885-026-16664-1}
}

RIS

TY  - JOUR
TI  - Prognostic impact of the Gustave Roussy Immune score in metastatic renal cell carcinoma treated with first-line immunotherapy-based combinations: results from the Turkish Oncology Group Kidney Cancer Consortium (TKCC)
AU  - Aysun Fatma Akkuş
AU  - Hatice Bölek
AU  - Esma Kaplan Tüzün
AU  - Elif Serteşen Camöz
AU  - Safa Can Efil
AU  - Murad Guliyev
AU  - Selver Işık
AU  - Caner Kapar
AU  - Serhat Sekmek
AU  - Halil Göksel Güzel
AU  - Sercan Ön
AU  - Sema Sezin Göksu
AU  - Özlem Nuray Sever
AU  - Çagatay Arslan
AU  - Nuri Karadurmuş
AU  - Musfafa Özgüroğlu
AU  - Mehmet Ali Nahit Sendur
AU  - Deniz Tural
AU  - Muhammet Bekir Hacıoğlu
AU  - Emre Yekedüz
AU  - Yüksel Ürün
PY  - 2026
JO  - BMC Cancer
DO  - 10.1186/s12885-026-16664-1
UR  - https://doi.org/10.1186/s12885-026-16664-1
ER  -

APA

Akkuş, A. F., Bölek, H., Tüzün, E. K., Camöz, E. S., Efil, S. C., Guliyev, M., Işık, S., Kapar, C., Sekmek, S., Güzel, H. G., Ön, S., Göksu, S. S., Sever, Ö. N., Arslan, Ç., Karadurmuş, N., Özgüroğlu, M., Sendur, M. A. N., Tural, D., Hacıoğlu, M. B., Yekedüz, E., & Ürün, Y. (2026). Prognostic impact of the Gustave Roussy Immune score in metastatic renal cell carcinoma treated with first-line immunotherapy-based combinations: results from the Turkish Oncology Group Kidney Cancer Consortium (TKCC). BMC Cancer. https://doi.org/10.1186/s12885-026-16664-1

Source records

crossref · retrieved 2026-11-08T00:13:52.956Z